PATENT CLAIM ANALYSIS

Application Number: 16043219
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-12
Patent Classification: ["514", "254040"]

Abstract:
The present invention relates to a medicament comprising lurasidone or a pharmaceutically acceptable acid addition salt thereof for treating pervasive developmental disorders and a method of the treatment thereof.

Claim (Index 4):
The method of  claim 3  wherein the pervasive developmental disorder is selected from the group consisting of atypical autism, Rett's syndrome, other childhood disintegrative disorder, overactive disorder associated with mental retardation and stereotyped movements, and Asperger's syndrome.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 95.0
- Lexical Diversity: 1.11111
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13827655', '15892144', '15316110', '13876108', '15004218']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8001806252942151
- 35 USC 102 Novelty (BERT): 0.548791767353373
- Combined Prediction Score: 0.7750417395001309
- Mean Citation Score: 273.456884
- Max Citation Score: 440.79074
- Similarity Product: 272.21282424867746

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test